Kuehne + Nagel, a global transport and logistics company based in Switzerland, is strengthening its pharma logistics offering in Chile with new logistics hub.
As of August 2018, a new Logistics Hub in Santiago de Chile will benefit the growing pharma & healthcare industry in South America with a dedicated warehousing solution. This provides Kuehne + Nagel’s global KN PharmaChain network, the multi-modal logistics solution for temperature-controlled door-to-door transportation, with an enhanced regional footprint.
The new facility further underlines Kuehne + Nagel’s continuous commitment to expand its GXP compliant warehousing and forwarding services worldwide.
While eco-friendly built and equipped, the Logistics Hub complies with the highest security standards and state-of-the-art technology to increase current operational capacities.
The facility will provide an area of 17,600 sqm for storage and distribution of temperature-sensitive products, which can be extended to 23,300 sqm, including a cold chamber to handle temperature requirements of 15 to 25°C and 2 to 8°C.
A renewed laboratory for quality control allows customers to comply with the regulatory requirement to carry out local analysis of imported pharmaceutical products. Additionally, GMP compliant repackaging and relabelling areas following Chilean and international specifications will be available as value added services.
The Logistics Hub will use clean energy via a geothermal system to keep the temperature of its general area between 15 to 25°C. By occupying the air that circulates through the subfloor a significant reduction of energy consumption will be achieved.
Kuehne + Nagel South & Central America president Ingo Goldhammer said: “With more than 40 years demonstrating commitment to the Chilean market, this cutting-edge facility will leverage the knowledge and experience of our specialised teams and enable Kuehne + Nagel to offer its unique pharma solutions to an extended customer base. This investment is in line with our strategic ongoing commitment to the pharma & healthcare industry globally strengthening our position as a leading player in pharma logistics.”